• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 介导的心脏损伤的表现和机制。

Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury.

机构信息

Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Int J Biol Sci. 2022 Mar 28;18(7):2703-2713. doi: 10.7150/ijbs.69677. eCollection 2022.

DOI:10.7150/ijbs.69677
PMID:35541905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9066113/
Abstract

Coronavirus disease 2019 (COVID-19), a global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) had resulted in considerable morbidity and mortality. COVID-19 primarily posed a threat to the respiratory system and violated many different organs, including the heart, kidney, liver, and blood vessels with the development of the disease. Severe patients were often accompanied by cardiac injury, and once the heart gets damaged, the mortality of patients will significantly increase. The main clinical manifestations of cardiac injury range from myocarditis, heart failure (HF), arrhythmia, and Takotsubo cardiomyopathy (TCM). A high abundance of angiotensin-converting enzyme II (ACE2) on the membrane of cardiomyocytes makes it possible that the virus can directly attack cardiomyocytes as subsequently evidenced by the detection of spike protein and virus RNA in autopsy cardiac tissues. The secondary myocardial injury through systemic inflammatory and immune response also caused obvious cardiac damage. The pathological manifestations of heart tissue were diverse, varied from mild cardiomyocyte edema, myocardial hypertrophy, cardiomyocyte degeneration, and necrosis to severe myocarditis caused by lymphocyte and macrophage infiltration. However, the mechanism of heart injury was still unclear. Here, we summarized the clinical manifestations and mechanism of SARS-CoV2 mediated cardiac injury, providing a reference for cardiac treatment in critically ill patients.

摘要

2019 年冠状病毒病(COVID-19)是一种由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV2)引起的全球大流行疾病,导致了相当高的发病率和死亡率。COVID-19 主要威胁呼吸系统,并随着疾病的发展侵犯许多不同的器官,包括心脏、肾脏、肝脏和血管。重症患者常伴有心脏损伤,一旦心脏受损,患者的死亡率将显著增加。心脏损伤的主要临床表现包括心肌炎、心力衰竭(HF)、心律失常和 Takotsubo 心肌病(TCM)。心肌细胞膜上大量存在的血管紧张素转换酶 2(ACE2)使得病毒有可能直接攻击心肌细胞,随后在尸检心脏组织中检测到刺突蛋白和病毒 RNA 进一步证实了这一点。全身性炎症和免疫反应引起的继发性心肌损伤也导致了明显的心脏损伤。心脏组织的病理表现多种多样,从轻度心肌细胞水肿、心肌肥厚、心肌细胞变性、坏死到淋巴细胞和巨噬细胞浸润引起的严重心肌炎不等。然而,心脏损伤的机制仍不清楚。在这里,我们总结了 SARS-CoV2 介导的心脏损伤的临床表现和机制,为危重症患者的心脏治疗提供了参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/9066113/b079f01c6426/ijbsv18p2703g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/9066113/b079f01c6426/ijbsv18p2703g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/9066113/b079f01c6426/ijbsv18p2703g001.jpg

相似文献

1
Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury.SARS-CoV-2 介导的心脏损伤的表现和机制。
Int J Biol Sci. 2022 Mar 28;18(7):2703-2713. doi: 10.7150/ijbs.69677. eCollection 2022.
2
Infiltrating monocytes drive cardiac dysfunction in a cardiomyocyte-restricted mouse model of SARS-CoV-2 infection.浸润单核细胞驱动 SARS-CoV-2 感染的心肌细胞特异性小鼠模型的心功能障碍。
J Virol. 2024 Sep 17;98(9):e0117924. doi: 10.1128/jvi.01179-24. Epub 2024 Aug 29.
3
Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.单细胞 RNA 分析 ACE2 表达可深入了解 SARS-CoV-2 进入血液和心脏损伤的潜在机制。
J Cell Physiol. 2020 Dec;235(12):9884-9894. doi: 10.1002/jcp.29802. Epub 2020 Jun 8.
4
COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?COVID-19 大流行与肌钙蛋白:间接性心肌损伤、心肌炎症还是心肌炎?
Heart. 2020 Aug;106(15):1127-1131. doi: 10.1136/heartjnl-2020-317186. Epub 2020 Jun 4.
5
Wuhan 3 years after the outbreak of the pandemic-cardiological insights and perspectives.新冠疫情爆发三年后的武汉:心脏医学的洞察与展望。
Herz. 2023 Jun;48(3):173-179. doi: 10.1007/s00059-023-05176-4. Epub 2023 Apr 27.
6
Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?严重急性呼吸综合征新型冠状病毒 2 感染过程中临床疑似心肌炎:事实还是虚构?
J Card Fail. 2021 Jan;27(1):92-96. doi: 10.1016/j.cardfail.2020.11.002. Epub 2020 Nov 6.
7
Histologic, viral, and molecular correlates of heart disease in fatal COVID-19.COVID-19 致死病例中心脏病的组织学、病毒学和分子相关性。
Ann Diagn Pathol. 2022 Oct;60:151983. doi: 10.1016/j.anndiagpath.2022.151983. Epub 2022 May 29.
8
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study.SARS-CoV-2、心肌损伤和炎症:来自一项大型临床和尸检研究的见解。
Clin Res Cardiol. 2021 Nov;110(11):1822-1831. doi: 10.1007/s00392-021-01910-2. Epub 2021 Jul 19.
9
Covid-19 and development of heart failure: mystery and truth.Covid-19 与心力衰竭的发生:扑朔迷离与真相大白。
Naunyn Schmiedebergs Arch Pharmacol. 2021 Oct;394(10):2013-2021. doi: 10.1007/s00210-021-02147-6. Epub 2021 Sep 4.
10
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.糖尿病中糖化 ACE2 受体:SARS-COV-2 进入心肌细胞的门户。
Cardiovasc Diabetol. 2021 May 7;20(1):99. doi: 10.1186/s12933-021-01286-7.

引用本文的文献

1
Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury.免疫调节:对抗SARS-CoV-2诱导的心肌损伤的关键。
Front Immunol. 2025 May 14;16:1561946. doi: 10.3389/fimmu.2025.1561946. eCollection 2025.
2
Effects of a Three-Day vs. Six-Day Exposure to Normobaric Hypoxia on the Cardiopulmonary Function of Rats.三天与六天常压缺氧暴露对大鼠心肺功能的影响
Curr Issues Mol Biol. 2025 Feb 14;47(2):125. doi: 10.3390/cimb47020125.
3
Mesenchymal stem cells derived exosomes: a new era in cardiac regeneration.间充质干细胞衍生的外泌体:心脏再生的新时代。

本文引用的文献

1
Cell specific peripheral immune responses predict survival in critical COVID-19 patients.细胞特异性外周免疫反应可预测重症 COVID-19 患者的生存情况。
Nat Commun. 2022 Feb 15;13(1):882. doi: 10.1038/s41467-022-28505-3.
2
Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer.评估有或无癌症的美国 COVID-19 患者的死亡率和不良结局。
JAMA Oncol. 2022 Jan 1;8(1):69-78. doi: 10.1001/jamaoncol.2021.5148.
3
Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes.
Stem Cell Res Ther. 2025 Jan 23;16(1):16. doi: 10.1186/s13287-024-04123-2.
4
The Potential Mechanisms of Arrhythmia in Coronavirus disease-2019.新型冠状病毒 2019 型心律失常的潜在机制。
Int J Med Sci. 2024 May 19;21(7):1366-1377. doi: 10.7150/ijms.94578. eCollection 2024.
5
Mapping the vast landscape of multisystem complications of COVID-19: Bibliometric analysis.绘制2019冠状病毒病多系统并发症的广阔图景:文献计量分析
Heliyon. 2024 May 4;10(9):e30760. doi: 10.1016/j.heliyon.2024.e30760. eCollection 2024 May 15.
6
Decoding HiPSC-CM's Response to SARS-CoV-2: mapping the molecular landscape of cardiac injury.解析 hiPSC-CM 对 SARS-CoV-2 的反应:绘制心脏损伤的分子图谱。
BMC Genomics. 2024 Mar 12;25(1):271. doi: 10.1186/s12864-024-10194-5.
7
Pathomorphological Features of the Novel Coronavirus Disease in Patients with Systemic Amyloidosis.系统性淀粉样变性患者新型冠状病毒病的病理形态学特征
Biomedicines. 2023 Oct 17;11(10):2811. doi: 10.3390/biomedicines11102811.
8
Serial echocardiographic evaluation of COVID-19 patients without prior history of structural heart disease: a 1-year follow-up CRACoV-HHS study.对无结构性心脏病既往史的COVID-19患者进行系列超声心动图评估:一项为期1年的CRACoV-HHS随访研究。
Front Cardiovasc Med. 2023 Sep 13;10:1230669. doi: 10.3389/fcvm.2023.1230669. eCollection 2023.
9
SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication.SARS-CoV-2合胞体未被关注:刺突蛋白诱导合胞体的分子见解及限制SARS-CoV-2复制的潜在策略
J Clin Med. 2023 Sep 20;12(18):6079. doi: 10.3390/jcm12186079.
10
Cardiac Involvement in COVID-19: A Global Bibliometric and Visualized Analysis.新型冠状病毒肺炎的心脏受累:一项全球文献计量学与可视化分析
Front Cardiovasc Med. 2022 Jul 27;9:955237. doi: 10.3389/fcvm.2022.955237. eCollection 2022.
肿瘤坏死因子-α加剧 SARS-CoV2 感染的诱导多能干细胞衍生心肌细胞中的病毒进入。
Int J Mol Sci. 2021 Sep 13;22(18):9869. doi: 10.3390/ijms22189869.
4
COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives.新型冠状病毒肺炎与急性冠状动脉综合征:从病理生理学到临床观点。
Oxid Med Cell Longev. 2021 Aug 30;2021:4936571. doi: 10.1155/2021/4936571. eCollection 2021.
5
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae.2019冠状病毒病与心力衰竭:从大流行期间的流行病学到心肌损伤、心肌炎及心力衰竭后遗症
Front Cardiovasc Med. 2021 Aug 10;8:713560. doi: 10.3389/fcvm.2021.713560. eCollection 2021.
6
Case Series of Clinical Findings of Multi-System Inflammatory Syndrome in Children in Contrast to Kawasaki Disease.与川崎病对比的儿童多系统炎症综合征临床发现病例系列
Cureus. 2021 Jul 17;13(7):e16446. doi: 10.7759/cureus.16446. eCollection 2021 Jul.
7
Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2.心肌细胞在感染 SARS-CoV-2 时通过分泌 CCL2 招募单核细胞。
Stem Cell Reports. 2021 Sep 14;16(9):2274-2288. doi: 10.1016/j.stemcr.2021.07.012. Epub 2021 Jul 20.
8
Myocarditis With COVID-19 mRNA Vaccines.COVID-19 mRNA 疫苗相关心肌炎。
Circulation. 2021 Aug 10;144(6):471-484. doi: 10.1161/CIRCULATIONAHA.121.056135. Epub 2021 Jul 20.
9
Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.探索性分析以确定研究 SARS-CoV-2 感染的最佳抗原和最佳免疫生物标志物。
J Transl Med. 2021 Jun 26;19(1):272. doi: 10.1186/s12967-021-02938-8.
10
Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19).2019年冠状病毒病(COVID-19)重症患者队列中快速性心律失常与死亡率之间的关联。
Ann Transl Med. 2021 May;9(10):883. doi: 10.21037/atm-21-2282.